Association study of the tumor necrosis factor-α gene and its 1A receptor gene with methamphetamine dependence

Annals of the New York Academy of Sciences

Volumn 1074, Issue , 2006, Pages 116-124

  Nomura, A ^a,b,c   Ujike, Hiroshi ^a,b   Tanaka, Y ^a   Kishimoto, M ^a   Otani, K ^a   Morita, Y ^a   Morio, A ^a   Harano, M ^b,d   Inada, T ^b,e   Yamada, M ^b,f   Komiyama, T ^b,f   Hori, T ^b,f   Sekine, Y ^b,g   Iwata, N ^b,h   Sora, I ^b,i   Iyo, M ^b,j   Ozaki, N ^a,k   Kuroda, S ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Japanese Genetics Initiative for Drug Abuse (JGIDA)   (Japan)

^c Kasaoka Hospital   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^g HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j CHIBA UNIVERSITY   (Japan)

^k NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Case control association study; Substance dependence; Tumor necrosis factor

Indexed keywords

DNA; MESSENGER RNA; METHAMPHETAMINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 1A; UNCLASSIFIED DRUG;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ABUSE; EXON; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PROMOTER REGION; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TNFALPHA GENE; TNFR SF1A GENE;

EID: 33749573646     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1369.011     Document Type: Conference Paper

References (17)

1. REHM, J., R. ROOM, W. VAN DEN BRINKT, et al. 2005. Problematic drug use and drug use disorders in EU countries and Norway: an overview of the epidemiology. Eur. Neuropsychopharmacol. 15: 389-397.
2. ANGLIN, M.D., C. BURKE, B. PERROCHET, et al. 2000. History of the methaniphetamine problem. J. Psychoactive Drugs 32: 137-141.
3. UJIKE, H. & M. SATO. 2004. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann. N. Y. Acad. Sci. 1025: 279-287.
4. TSUANG, M.T., M.J. LYNONS, S.A. EISEN, et al. 1996. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. Am. J. Med. Genet. 67: 473-477.
5. VASSALI, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10: 411-452.
6. FLORA, G., Y.W. LEE, A. NATH, et al. 2002. Methamphetamine-induced TNF-alpha gene expression and activation of AP-1 in discrete regions of mouse brain: potential role of reactive oxygen intermediates and lipid peroxidation. Neuromolecular Med. 2: 71-85.
7. JAYANTHI, S., M.T. MCCOY, B. LADENHEIM, et al. 2002. Methamphetamine causes coordinate regulation of Src, Cas, Crk, and the Jun N-terminal kinase-Jun pathway. Mol. Pharmacol. 61: 1124-1131.
8. YAMADA, K. & T. NABESHIMA. 2004. Pro- and anti-addictive neurotrophic factors and cytokines in psychostimulant addiction: mini-review. Ann. N. Y. Acad. Sci. 1025: 198-204.
9. NAKAJIMA, A., K. YAMADA, T. NAGAI, et al. 2004. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity. J. Neurosci. 24: 2212-2225.
10. WILSON, A.G., N. DE VRIES, F. POCIOT, et al. 1993. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J. Exp. Med. 177: 557-560.
11. KROEGER, K.M., K.S. CARVILLE & L.J. ABRAHAM. 1997. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol. Immunol. 34: 391-399.
12. WILSON, A.G., G.W. DUFF, H.O. MCDEVITT, et al. 1997. Effects of a polymorphism in the human tumor necrosis factor promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 94: 3195-3199.
13. HIGUCHI, T., N. SEKI, S. KAMIZONO, et al. 1998. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51: 605-612.
14. MCDERMOTT, M.F., I. AKSENTIJEVICH, J. GALON, et al. 1999. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97: 133-144.
15. AKSENTIJEVICH, I., J. GALON, M. SOARES, et al. 2001. The tumour necrosis factor receptor-associated periodic syndrome: new mutations in TNFR-SF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am. J. Hum. Genet. 269: 301-314.
16. GLOSSOP, J.R., P.T. DAWES, A.B. HASSELL, et al. 2005. Anemia in rheumatoid arthritis: association with polymorphism in the tumor necrosis factor receptor I and II genes. J. Rheumatol. 32: 1673-1678.
17. DIEUDE, P., J. OSORIO, E. PETIT-TEIXEIRA, et al. 2004. European Consortium on Rheumatoid Arthritis Families. A TNFR1 genotype with a protective role in familial rheumatoid arthritis. Arthritis Rheum. 50: 413-419.